Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.
about
H5N1 viruses and vaccinesRecombinant Newcastle disease virus as a vaccine vector for cancer therapyProtection and virus shedding of falcons vaccinated against highly pathogenic avian influenza A virus (H5N1)Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary VaccinesCurrent Status of Veterinary VaccinesAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetNewcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.Viral vector-based influenza vaccines.Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesImmunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunityInduction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus.Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion siteVirus-vectored influenza virus vaccines.Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection.Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunityNonsegmented negative-strand viruses as vaccine vectors.Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and catsAvian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle diseaseAvian influenza virus hemagglutinins H2, H4, H8, and H14 support a highly pathogenic phenotypeRecombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challengeFormulation and delivery of vaccines: Ongoing challenges for animal management.Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in miceA combination in-ovo vaccine for avian influenza virus and Newcastle disease virus.Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickensNovel vaccine strategies against emerging viruses.Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience.Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus.Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza.The long view: a selective review of 40 years of Newcastle disease research.
P2860
Q21131612-1873ED49-6C4C-4909-B247-70D3D0089ED4Q24602728-2B947536-BEAA-44C4-BE3D-0A87FC1D66E4Q24603644-C281993B-C35C-4820-948C-EC8FED57691CQ26744220-AE484284-84A9-4898-B721-69F03789A7A6Q27480923-25EEB83B-1E42-456F-99F8-07F694CDEE9BQ30227194-C30F05AF-4D8C-4359-BD9D-6886A02224F3Q30357521-0B0161B9-4682-4699-9767-FD32EFAFD282Q30361939-4325E606-4583-4E57-AFAC-B96770EA97A0Q30363581-3E63E21A-CD06-4A5D-9CA5-8EFC57A00BC6Q30373784-7F5544B7-046B-4975-AB72-73536B2C155AQ30382097-87AD3DFD-F65B-49E8-B0EA-7F124FA76C29Q30382650-ACB66EFA-A496-424B-9AEE-A38CD9334A44Q30390938-BA1EA684-314C-41C4-A949-35804EF9DC1EQ30421007-D6729E69-4499-4FD3-BFEE-D8988EA833B9Q30427591-5B421BBD-4568-49DA-9470-6ACA55D9715FQ33490614-8130506D-5F03-4B9E-89DC-EEDA78A22BD0Q33648987-13E31443-E455-430D-8FED-B5A10FE9FE11Q33886452-33836F10-DD73-4FF6-BA19-757EB7B70D1FQ33983270-04AA1494-ADF1-4F99-A20B-25DBAF2253B5Q34102268-962CE4D0-F0C7-4C25-BA18-5003B4C77F0FQ34296139-A8EB4A67-C921-4BA4-B830-ED7DEB781594Q34542448-4503D219-0F12-4899-AA95-936B5C3B7769Q34613432-36068F0B-6ECF-4352-905C-A253B338E780Q34983940-ADA5A059-1071-4C88-A8DF-EA907D79DDD8Q35139219-C8E14976-76A4-4FC7-8A48-C5268888CEBBQ35140435-A5FA9CF7-7112-4F99-A5ED-3E52EB3C97BCQ35314472-EB252A45-BA41-45B3-A864-95F123134A5BQ35787246-AEE77564-A04A-480A-A886-C4C94A41E5DEQ36016500-59B72D67-22D5-4A14-A530-303D6E7F7FD6Q36470265-5A220748-BD69-4C89-A29B-B7A81E747E50Q36611663-D40A0D3D-CE7A-464D-A030-96782580E338Q36671033-5AF18BF7-F6EE-43DB-8B09-FE789E6B397EQ36692742-1DBEBA6A-FE32-4741-81DB-AFBB8DCFDAABQ36816140-BE937558-3D6F-4FA8-9C2F-2FE072AE284FQ36837166-3148AE0D-2342-4F6F-97A4-CD0939251A8BQ37242960-675FAC94-AA55-4169-B141-3E35C1393942Q37347267-208CF867-3542-4B22-AA44-CF42A95BA382Q37639531-790852F6-F956-41B4-BAD7-CD644551C15CQ37658883-00964539-20AF-4F3A-94E7-7B5A6D9E632BQ38029720-32ED45AF-94E6-4FB4-9AE0-768DAC58985F
P2860
Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Newcastle disease virus expres ...... e disease and avian influenza.
@ast
Newcastle disease virus expres ...... e disease and avian influenza.
@en
Newcastle disease virus expres ...... e disease and avian influenza.
@nl
type
label
Newcastle disease virus expres ...... e disease and avian influenza.
@ast
Newcastle disease virus expres ...... e disease and avian influenza.
@en
Newcastle disease virus expres ...... e disease and avian influenza.
@nl
prefLabel
Newcastle disease virus expres ...... e disease and avian influenza.
@ast
Newcastle disease virus expres ...... e disease and avian influenza.
@en
Newcastle disease virus expres ...... e disease and avian influenza.
@nl
P2093
P2860
P356
P1476
Newcastle disease virus expres ...... e disease and avian influenza.
@en
P2093
Angela Römer-Oberdörfer
Bernd Hoffmann
Dorothee Wiesner
Egbert Mundt
Elke Starick
Harald Granzow
Horst Schirrmeier
Jutta Veits
Teshome Mebatsion
Walter Fuchs
P2860
P304
P356
10.1073/PNAS.0602461103
P407
P577
2006-05-22T00:00:00Z